Literature DB >> 26663608

Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation.

Andres F Carrion1, Saira A Khaderi2, Norman L Sussman2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26663608     DOI： 10.1002/lt.24383

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  11 in total

1.  Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals.

Authors:  Sumeyye Samur; Brian Kues; Turgay Ayer; Mark S Roberts; Fasiha Kanwal; Chin Hur; Drew Michael S Donnell; Raymond T Chung; Jagpreet Chhatwal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-17       Impact factor: 11.382

2.  Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.

Authors:  Jagpreet Chhatwal; Sumeyye Samur; Brian Kues; Turgay Ayer; Mark S Roberts; Fasiha Kanwal; Chin Hur; Drew Michael S Donnell; Raymond T Chung
Journal:  Hepatology       Date:  2017-01-06       Impact factor: 17.425

Review 3.  Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges.

Authors:  Sirina Ekpanyapong; K Rajender Reddy
Journal:  United European Gastroenterol J       Date:  2019-03-21       Impact factor: 4.623

Review 4.  Remaining clinical issues in hepatitis C treatment.

Authors:  Alexander Wong; Cynthia Tsien; Sarah Mansour; Curtis Cooper
Journal:  Can Liver J       Date:  2018-07-17

5.  Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection.

Authors:  Elliot B Tapper; Neehar D Parikh; Pamela K Green; Kristin Berry; Akbar K Waljee; Andrew M Moon; George N Ioannou
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-04       Impact factor: 11.382

6.  Spontaneous bacterial peritonitis prevalence in pre-transplant patients and its effect on survival and graft loss post-transplant.

Authors:  Neeral L Shah; Nicolas M Intagliata; Zachary H Henry; Curtis K Argo; Patrick G Northup
Journal:  World J Hepatol       Date:  2016-12-28

Review 7.  Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.

Authors:  George Cholankeril; Mairin Joseph-Talreja; Brandon J Perumpail; Andy Liu; Eric R Yoo; Aijaz Ahmed; Aparna Goel
Journal:  J Clin Transl Hepatol       Date:  2017-09-14

8.  'It's been a long haul, a big haul, but we've made it': hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysis.

Authors:  Anna Krzeczkowska; Paul Flowers; Zoe Chouliara; Peter Hayes; Adele Dickson
Journal:  Health Psychol Open       Date:  2018-08-06

Review 9.  Transplanting Organs from Donors with HIV or Hepatitis C: The Viral Frontier.

Authors:  Brian J Boyarsky; Alexandra T Strauss; Dorry L Segev
Journal:  World J Surg       Date:  2021-01-20       Impact factor: 3.352

Review 10.  Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.

Authors:  Chiranjeevi Gadiparthi; George Cholankeril; Brandon J Perumpail; Eric R Yoo; Sanjaya K Satapathy; Satheesh Nair; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.